A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
2 other identifiers
interventional
528
1 country
24
Brief Summary
To investigate the appropriate zalcitabine ( dideoxycytidine; ddC ) dose and zidovudine ( AZT ) schedule for use in combination therapy in patients with HIV infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 hiv-infections
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 1999
CompletedFirst Posted
Study publicly available on registry
August 31, 2001
CompletedJune 24, 2005
February 1, 1995
November 2, 1999
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Patients must have:
- HIV infection.
- CD4 count 100 - 500 cells/mm3.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (24)
Kaiser Foundation Hosp
Harbor City, California, 90710, United States
Kaiser Permanente Med Ctr
Los Angeles, California, 90027, United States
Sharp Rees - Stealy Med Group
San Diego, California, 92101, United States
UCSF - San Francisco Gen Hosp
San Francisco, California, 94110, United States
Denver Public Health Dept / Disease Control Services
Denver, Colorado, 80204, United States
Howard Univ
Washington D.C., District of Columbia, 20060, United States
Veterans Administration Med Ctr
Washington D.C., District of Columbia, 20422, United States
Miami Veterans Administration Med Ctr
Miami, Florida, 33125, United States
Univ of Miami School of Medicine
Miami, Florida, 33136, United States
Intergrated Care Ctr
Atlanta, Georgia, 30327, United States
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois, 60612, United States
Univ of Kansas School of Medicine
Wichita, Kansas, 67214, United States
New England Med Ctr
Boston, Massachusetts, 02111, United States
St Paul Ramsey Med Ctr / HIV Program Office
Saint Paul, Minnesota, 55101, United States
Washington Univ
St Louis, Missouri, 63110, United States
Univ of New Mexico School of Medicine
Albuquerque, New Mexico, 87131, United States
SUNY / Health Sciences Ctr at Brooklyn
Brooklyn, New York, 11203, United States
Saint Luke's - Roosevelt Hosp Ctr
New York, New York, 10019, United States
Bronx Veterans Affairs Med Ctr
The Bronx, New York, 10468, United States
Ohio State Univ Hosp Clinic
Columbus, Ohio, 432101228, United States
Oregon Health Sciences Univ
Portland, Oregon, 97201, United States
N Texas Ctr for AIDS & Clin Rsch
Dallas, Texas, 75219, United States
Univ TX Galveston Med Branch
Galveston, Texas, 775550882, United States
Dr Brian Buggy
Milwaukee, Wisconsin, 53215, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 2, 1999
First Posted
August 31, 2001
Last Updated
June 24, 2005
Record last verified: 1995-02